Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Sep;29(5):582-94.
doi: 10.1007/s10875-009-9304-x. Epub 2009 Jun 10.

Chronic arsenic exposure impairs macrophage functions in the exposed individuals

Affiliations

Chronic arsenic exposure impairs macrophage functions in the exposed individuals

Nilanjana Banerjee et al. J Clin Immunol. 2009 Sep.

Abstract

Introduction: Owing to the established roles of human macrophages in immune defense, we investigated the effect of chronic arsenic exposure upon these major hematopoietic cells in 70 arsenic-exposed individuals with skin lesions and 64 unexposed individuals.

Methods: Human monocyte-derived macrophages were prepared from peripheral blood mononuclear cells, by culture of the adherent cells for 6 days in medium supplemented with granulocyte-monocyte colony stimulating factor. Parameters studied included cell adhesion capacity, expression of CD54 and F-actin, nitric oxide production, phagocytic capacity, and effect of arsenic on Rho A-ROCK pathway.

Results: In macrophages of exposed individuals when compared to unexposed group, there was cell rounding accompanied with a significant (p < 0.001) loss of cell adhesion capacity, decrease in nitric oxide production, impaired phagocytic capacity, and decreased CD 54 and F-actin expression. Additionally, chronic arsenic exposure affected Rho A-ROCK pathway which in turn impaired macrophage functions.

Discussion and conclusion: These altogether could contribute significantly to arsenic-induced immunosuppression observed in the arsenic-exposed individuals.

PubMed Disclaimer

References

    1. Int Immunopharmacol. 2004 Dec 15;4(13):1661-73 - PubMed
    1. J Expo Sci Environ Epidemiol. 2007 May;17(3):215-23 - PubMed
    1. Carcinogenesis. 2007 Mar;28(3):672-6 - PubMed
    1. J Toxicol Clin Toxicol. 2001;39(7):683-700 - PubMed
    1. Toxicology. 2008 Apr 18;246(2-3):101-11 - PubMed

Publication types

MeSH terms

LinkOut - more resources